During the past decade, PPD Development, LP conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "PPD Development, LP" are "Healthy Volunteers" (2 trials), "Healthy Participants" (1 trials), "Non-alcoholic Fatty Liver Disease" (1 trials) and "Non-alcoholic Steatohepatitis" (1 trials). Many other conditions were trialed in "PPD Development, LP" in a lesser frequency.

Most popular intervention types in "PPD Development, LP" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Maribavir (200 mg)" (1 trials), "Maribavir (400 mg)" (1 trials), "Maribavir (800 mg)" (1 trials), "PF-06865571" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "PPD Development, LP" are 4 trials for "All" genders.

Currently, there are NaN active trials in "PPD Development, LP". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in PPD Development, LP, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PPD Development, LP, 4 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".